Sweat gland hyperhidrosis - Symptoms, Causes, Treatment & Prevention

```html

Overview

Hyperhidrosis is a medical condition characterized by excessive sweating beyond what is needed for thermoregulation. When the problem originates from the sweat glands themselves rather than a secondary cause (e.g., fever, medication), it is called **primary sweat‑gland hyperhidrosis**. It most commonly affects the palms, soles, underarms, and face, but any area with sweat glands can be involved.

• Who it affects: Both sexes, all ages, although onset is usually before age 25. Women report slightly higher prevalence, likely because social pressures around appearance make them more likely to seek care.
• Prevalence: Studies estimate that 1–3 % of the global population has clinically significant hyperhidrosis. In the United States, roughly 4.8 million adults are affected (Mayo Clinic, 2022).
• Impact: Excessive sweating can impair daily activities, cause emotional distress, and lead to secondary skin infections.

Symptoms

Symptoms vary according to the region of the body involved (known as “focal” hyperhidrosis) or may be widespread (“generalized”). All symptoms share the hallmark of sweat that is:

• Profuse (often soaking through clothing within minutes)
• Persistent (present daily for at least six weeks)
• Disproportionate to temperature, activity level, or emotional state

Focal Hyperhidrosis

• Palmar hyperhidrosis: Wet palms that make writing, holding tools, or shaking hands difficult.
• Plantar hyperhidrosis: Damp soles, leading to slippery shoes and foot odor.
• Axillary hyperhidrosis: Soaked underarms, often causing staining of clothing.
• Craniofacial hyperhidrosis: Excessive sweating of the forehead, scalp, or face.
• Breast or nipple hyperhidrosis: Rare but can cause chafing under clothing.

Generalized Hyperhidrosis

• Excessive sweating over the entire body, including the trunk and limbs.
• Night sweats that disrupt sleep.
• Associated symptoms such as heat intolerance, fatigue, or mood changes (often secondary to embarrassment).

Causes and Risk Factors

Hyperhidrosis is divided into two categories:

Primary (Idiopathic) Hyperhidrosis

• Thought to be due to over‑activity of the sympathetic nervous system—specifically the cholinergic nerves that stimulate eccrine sweat glands.
• Often runs in families; a positive family history is reported in up to 50 % of cases, suggesting a genetic component.

Secondary Hyperhidrosis

Occurs when another medical condition or medication triggers excessive sweating.

• Endocrine disorders: Hyperthyroidism, menopause, diabetes, pheochromocytoma.
• Infections: Tuberculosis, HIV, endocarditis, chronic hepatitis.
• Neurologic conditions: Parkinson’s disease, spinal cord injury.
• Medications: Antidepressants (SSRIs, tricyclics), antipyretics (aspirin), hormone therapy.
• Other: Obesity, anxiety disorders, chronic pain, substance use (alcohol, caffeine).

Risk Factors

• Positive family history
• Age < 25 (most cases begin in childhood or adolescence)
• Obesity (increases overall sweat production)
• High‑stress occupations or lifestyle (e.g., public speaking, performing arts)
• Certain ethnicities: studies suggest higher prevalence among Caucasian and Asian populations compared with African‑American groups, though data are limited.

Diagnosis

Diagnosis is primarily clinical, based on history and physical exam. A stepwise approach helps differentiate primary from secondary causes.

History

• Onset age, pattern (focal vs. generalized), triggers, and duration.
• Impact on daily life (work, social activities, sleep).
• Medication review and review of systemic symptoms (fever, weight loss, palpitations).
• Family history of hyperhidrosis.

Physical Examination

• Observation of sweating in a controlled environment (room temperature 24‑26 °C, low humidity).
• Skin assessment for maceration, fungal infections, or dermatitis.

Diagnostic Tests (when secondary cause suspected)

• Blood work: CBC, fasting glucose, TSH, fasting catecholamines.
• Urine or plasma metanephrines: To rule out pheochromocytoma.
• Imaging: Chest X‑ray or CT if infection or neoplasm is suspected.
• Starch‑iodine test (Minor’s test): Applies iodine and starch to the skin; sweat turns the mixture dark, allowing precise mapping of hyperactive zones before procedures.

Severity Grading

Clinicians often use the Hyperhidrosis Disease Severity Scale (HDSS) or the Dermatology Life Quality Index (DLQI) to quantify impact and guide treatment intensity.

Treatment Options

Treatment is individualized, considering severity, anatomic site, comorbidities, and patient preference. Options range from lifestyle measures to minimally invasive procedures and surgery.

1. Topical Therapies

• Aluminum chloride hexahydrate (e.g., Drysol): First‑line for axillary and palmar hyperhidrosis. Apply at night; common side effect is skin irritation.
• Clinical‑strength antiperspirants (20‑30 % aluminum): Over‑the‑counter alternatives for mild cases.

2. Systemic Medications

• Anticholinergics (glycopyrrolate, oxybutynin): Decrease sweat production by blocking muscarinic receptors. Effective for generalized hyperhidrosis; monitor for dry mouth, blurred vision, urinary retention.
• Beta‑blockers or benzodiazepines: Helpful when anxiety triggers sweating.
• Topical 20 % glycopyrrolate cream: Emerging option with fewer systemic side effects (studies show 30‑40 % reduction in sweat volume).

3. Botulinum Toxin Injections (Botox®)

• Blocks acetylcholine release at the neuromuscular junction of sweat glands.
• FDA‑approved for axillary hyperhidrosis; off‑label for palms, soles, and face.
• Effect lasts 4‑12 months; repeat injections required.
• Side effects: temporary muscle weakness, bruising.

4. Iontophoresis

• Non‑invasive electrical current delivered through water; most effective for palmar and plantar hyperhidrosis.
• Typical regimen: 20‑30 minutes daily for 2 weeks, then maintenance 2–3 times weekly.
• Adverse events are rare; mild skin irritation may occur.

5. Oral or Injectable Anticholinergic Alternatives

• Topical anticholinergic creams (e.g., glycopyrrolate 20 %): Ongoing trials suggest comparable efficacy to Botox for the face with less pain.

6. Laser and Energy‑Based Therapies

• Microwave thermolysis (e.g., MiraDry): Destroys sweat glands in the underarm using microwave energy. One‑time outpatient procedure; results sustained for ≥5 years in >80 % of patients (Cleveland Clinic, 2021).
• Laser ablation (CO₂, Nd:YAG): Less common, used for limited focal areas.

7. Surgical Options

• Endoscopic thoracic sympathectomy (ETS): Minimally invasive cutting or clipping of sympathetic nerves (usually T2‑T4) to treat severe palmar or axillary hyperhidrosis.
• Success rates >90 % for sweating reduction, but up to 5‑10 % experience compensatory sweating elsewhere—a significant drawback.
• Indicated only after conservative measures fail.

Choosing the Right Treatment

Clinical guidelines (American Academy of Dermatology, 2023) recommend a stepwise approach: start with topical agents → oral medications → procedural therapies (Botox, iontophoresis) → energy‑based devices → surgery. Shared decision‑making with a dermatologist or neurologist ensures the chosen plan aligns with the patient’s lifestyle and risk tolerance.

Living with Sweat Gland Hyperhidrosis

Beyond medical therapy, daily strategies can lessen the practical burden.

• Clothing: Choose loose, breathable fabrics (cotton, moisture‑wicking synthetics). Dark colors hide stains.
• Foot care: Use antiperspirant powder in shoes, change socks several times daily, and rotate footwear to allow drying.
• Personal hygiene: Shower twice daily; dry skin thoroughly before applying antiperspirants.
• Skin protection: Apply barrier creams or foot powders to prevent maceration and fungal infections.
• Stress management: Practice deep‑breathing, yoga, or cognitive‑behavioral techniques; anxiety often magnifies sweating.
• Dietary considerations: Limit caffeine, spicy foods, and alcohol, all of which can trigger sweating.
• Hydration: Replace fluid lost through sweating—prefer electrolyte solutions if sweating is profuse.
• Workplace accommodations: Request desk fans, breathable uniforms, or schedule frequent breaks if needed.
• Support groups: Online forums (e.g., Hyperhidrosis Support Network) provide emotional support and practical tips.

Prevention

Because primary hyperhidrosis is largely genetic, true prevention is limited. However, secondary hyperhidrosis can often be avoided:

• Maintain a healthy weight to reduce overall metabolic heat production.
• Manage chronic conditions (thyroid disease, diabetes) with regular medical follow‑up.
• Review medication lists with a physician; consider alternatives if a drug is known to cause sweating.
• Adopt stress‑reduction practices to limit anxiety‑related sweating.

Complications

If left untreated, hyperhidrosis may lead to:

• Skin infections: Bacterial (impetigo, cellulitis) and fungal (tinea pedis, candidiasis) infections thrive in moist environments.
• Dermatitis: Irritant or allergic contact dermatitis from frequent washing or antiperspirant use.
• Emotional and psychosocial impact: Anxiety, depression, social withdrawal, and reduced work productivity (studies report a 35 % decrease in quality‑of‑life scores comparable to severe psoriasis).
• Functional limitations: Impaired grip, slippage of objects, difficulty writing, or performing sports.
• Secondary sleep disturbance: Night sweats can lead to insomnia and daytime fatigue.

When to Seek Emergency Care

References

• Mayo Clinic. “Hyperhidrosis” 2022. https://www.mayoclinic.org
• American Academy of Dermatology. “Guidelines of Care for Primary Focal Hyperhidrosis” 2023.
• Cleveland Clinic. “Microwave Thermolysis (MiraDry) for Axillary Hyperhidrosis” 2021.
• National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). “Hyperhidrosis” 2022.
• World Health Organization. “Skin diseases” fact sheet 2023.
• J. S. Solish, et al. “Botulinum toxin type A for severe hyperhidrosis: a systematic review.” *Dermatol Surg*. 2020;46(5):678‑689.

```